Yong-Sheng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yong-Sheng Zhao has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Chuan Zhong
Department of Thoracic Surgery West China Hospital, Sichuan University Chengdu China
2 shared publications- Yi-Dan Lin
Department of Thoracic Surgery, West China Hospital, Sichuan University
2 shared publications Boyang Xia
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
1 shared publicationChuanfen Zhang
Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China
1 shared publicationDapeng Wang
Department of Intensive Medicine, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, China
1 shared publication- Dong Tian
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 11 (1) , 389
An integrated multiomic single-vesicle atlas delineates graft exosome heterogeneity in chronic lung allograft dysfunction
The underlying mechanisms of exosomes in chronic lung allograft dysfunction (CLAD) remain poorly understood. The primary challenge lies in the substantial functional heterogeneity of exosomes in CLAD. In this study, lung transplantation was initially performed, followed by the generation of a chronic rejection (CR) model in rats to simulate CLAD in humans. Exosomes from lung graft tissues were extracted, purified, and subjected to proximity barcoding assay-based single-vesicle membrane proteomic profiling. Additionally, bulk proteomic and metabolomic profiling of the graft tissues was conducted. Exosomes were categorized into 14 clusters. Compared with the syngeneic group, the CR group had significantly lower levels of clusters 7 (Nphs1 high ), 13 (Aqp1 high ), and 14 (Csf3r high ), and higher levels of clusters 2 (Lrp2 high Mrc1 high ) and 4 (Nt5e high ). The abundance of cluster 12 (Ilk high ) exosomes was strongly correlated with pleural thickness (r = −0.90, P < 0.001). Cluster 12 exosomes exhibited the greatest number of related differentially expressed proteins and metabolites. The proteins correlated with cluster 12 were enriched in the “complement and coagulation cascades”, whereas the metabolites were enriched in the “glycerophospholipid metabolism”. Further verification in patients with restrictive allograft syndrome revealed the same decrease in abundance of cluster 12 exosomes as that observed in the rat model. Finally, the core molecular network of cluster 12 that contributes to pleural thickening in CLAD was constructed. In this study, the heterogeneous composition of exosomes in lung grafts was mapped to expand the understanding of their effects and to drive their application in CLAD.
- 17 September 2026
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 11 (1) , 389
Open AccessAn integrated multiomic single-vesicle atlas delineates graft exosome heterogeneity in chronic lung allograft dysfunction
The underlying mechanisms of exosomes in chronic lung allograft dysfunction (CLAD) remain poorly understood. The primary challenge lies in the substantial functional heterogeneity of exosomes in CLAD. In this study, lung transplantation was initially performed, followed by the generation of a chronic rejection (CR) model in rats to simulate CLAD in humans. Exosomes from lung graft tissues were extracted, purified, and subjected to proximity barcoding assay-based single-vesicle membrane proteomic profiling. Additionally, bulk proteomic and metabolomic profiling of the graft tissues was conducted. Exosomes were categorized into 14 clusters. Compared with the syngeneic group, the CR group had significantly lower levels of clusters 7 (Nphs1 high ), 13 (Aqp1 high ), and 14 (Csf3r high ), and higher levels of clusters 2 (Lrp2 high Mrc1 high ) and 4 (Nt5e high ). The abundance of cluster 12 (Ilk high ) exosomes was strongly correlated with pleural thickness (r = −0.90, P < 0.001). Cluster 12 exosomes exhibited the greatest number of related differentially expressed proteins and metabolites. The proteins correlated with cluster 12 were enriched in the “complement and coagulation cascades”, whereas the metabolites were enriched in the “glycerophospholipid metabolism”. Further verification in patients with restrictive allograft syndrome revealed the same decrease in abundance of cluster 12 exosomes as that observed in the rat model. Finally, the core molecular network of cluster 12 that contributes to pleural thickening in CLAD was constructed. In this study, the heterogeneous composition of exosomes in lung grafts was mapped to expand the understanding of their effects and to drive their application in CLAD.
- Open Access
- 1 February 2026
- Published by Wiley in Thoracic Cancer
- Vol. 17 (3) , e70249
A Novel Intra‐Operative Irrigation‐Drainage System for Robot‐Assisted Thoracoscopic Esophagogastric Layered Anastomosis: Preliminary Practice and Short‐Term Clinical Outcomes
Robot‐assisted thoracoscopic surgery facilitates the execution of intrathoracic hand‐sewn layered anastomosis during minimally invasive esophagectomy. However, challenges persist due to the complex technical demands inherent in this procedure. Patients who received robot‐assisted Ivor‐Lewis esophagectomy with intrathoracic hand‐sewn layered anastomosis for esophageal cancer were enrolled. A novel irrigation‐drainage auxiliary system designed for robot‐assisted thoracoscopic esophagectomy was introduced to optimize the execution of intrathoracic hand‐sewn layered anastomosis. The anastomosis time, operation time, postoperative complications, and postoperative hospital stay were evaluated. A total of 30 patients were enrolled, and the application of this system resulted in a median anastomosis time of 37 min (range: 28–65). None of the patients experienced postoperative anastomotic leakage or pleural cavity infection, indicating satisfactory short‐term safety and efficacy. The device improved operative efficiency by providing better exposure of the anastomotic region, enabling complete abdominal and thoracic drainage and freeing the assistant's hands for other tasks.
- 1 February 2026
- Published by Wiley in Thoracic Cancer
- Vol. 17 (3) , e70249
Open AccessA Novel Intra‐Operative Irrigation‐Drainage System for Robot‐Assisted Thoracoscopic Esophagogastric Layered Anastomosis: Preliminary Practice and Short‐Term Clinical Outcomes
Robot‐assisted thoracoscopic surgery facilitates the execution of intrathoracic hand‐sewn layered anastomosis during minimally invasive esophagectomy. However, challenges persist due to the complex technical demands inherent in this procedure. Patients who received robot‐assisted Ivor‐Lewis esophagectomy with intrathoracic hand‐sewn layered anastomosis for esophageal cancer were enrolled. A novel irrigation‐drainage auxiliary system designed for robot‐assisted thoracoscopic esophagectomy was introduced to optimize the execution of intrathoracic hand‐sewn layered anastomosis. The anastomosis time, operation time, postoperative complications, and postoperative hospital stay were evaluated. A total of 30 patients were enrolled, and the application of this system resulted in a median anastomosis time of 37 min (range: 28–65). None of the patients experienced postoperative anastomotic leakage or pleural cavity infection, indicating satisfactory short‐term safety and efficacy. The device improved operative efficiency by providing better exposure of the anastomotic region, enabling complete abdominal and thoracic drainage and freeing the assistant's hands for other tasks.
- Open Access
- 1 August 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (8) , 5509-5523
Racial disparities in the cause of death among patients with lung cancer in the United States
Background: Racial disparities in lung cancer have existed in the United States (US) for many years. No studies have been conducted to elucidate the long-term trends of racial disparities in all-cause and cause-specific deaths in lung cancer patients. Our study aimed to explore trends and potential contributing factors of racial disparities. Methods: From the Surveillance, Epidemiology, and End Results (SEER) Program, we obtained the data of lung cancer patients diagnosed between 2000 and 2019, with follow-up until Dec 31, 2020. The cumulative mortality for Black, White, Asian or Pacific Islander (API), and American Indian or Alaska Native (AIAN) was calculated by diagnostic period and cause of death. By using Cox regression models, we determined the relative [hazard ratio (HR)] racial disparities and contributing factors. Results: The incidence and mortality rates during 2000–2019 for lung cancer decreased in all racial groups in men and women, especially for Black men. Despite a downward trend in the cumulative risk of death in racial groups, Black and API patients consistently had the highest and lowest mortality rates from 2000 to 2019, with adjusted HR of 1.14 and 0.83, respectively. The Black-White disparities in all-cause mortality narrowed over time, with adjusted HR of 1.18 [95% confidence interval (CI): 1.15–1.20] during 2000–2004 and 1.14 (95% CI: 1.11–1.16) during 2015–2019. Surgery and liver metastasis had the largest effect on Black-White disparities and API-White disparities, respectively. Conclusions: Our findings reveal persistent racial disparities among lung cancer patients, providing a theoretical basis for interventions to eliminate health disparities.
- 1 August 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (8) , 5509-5523
Open AccessRacial disparities in the cause of death among patients with lung cancer in the United States
Background: Racial disparities in lung cancer have existed in the United States (US) for many years. No studies have been conducted to elucidate the long-term trends of racial disparities in all-cause and cause-specific deaths in lung cancer patients. Our study aimed to explore trends and potential contributing factors of racial disparities. Methods: From the Surveillance, Epidemiology, and End Results (SEER) Program, we obtained the data of lung cancer patients diagnosed between 2000 and 2019, with follow-up until Dec 31, 2020. The cumulative mortality for Black, White, Asian or Pacific Islander (API), and American Indian or Alaska Native (AIAN) was calculated by diagnostic period and cause of death. By using Cox regression models, we determined the relative [hazard ratio (HR)] racial disparities and contributing factors. Results: The incidence and mortality rates during 2000–2019 for lung cancer decreased in all racial groups in men and women, especially for Black men. Despite a downward trend in the cumulative risk of death in racial groups, Black and API patients consistently had the highest and lowest mortality rates from 2000 to 2019, with adjusted HR of 1.14 and 0.83, respectively. The Black-White disparities in all-cause mortality narrowed over time, with adjusted HR of 1.18 [95% confidence interval (CI): 1.15–1.20] during 2000–2004 and 1.14 (95% CI: 1.11–1.16) during 2015–2019. Surgery and liver metastasis had the largest effect on Black-White disparities and API-White disparities, respectively. Conclusions: Our findings reveal persistent racial disparities among lung cancer patients, providing a theoretical basis for interventions to eliminate health disparities.